HOKKAIDO, Japan: In a recent study, researchers in Japan have developed a new way of testing bacterial resistance to antibiotics and while doing so found three previously unknown resistance mutations. With more and more pathogenic microorganisms developing immunity to widely used antibiotics, the discovery could be reassuring for many health professionals.
The researchers, from Hokkaido University and the National Institute of Advanced Industrial Science and Technology, have developed an approach to systematically screen for resistant ribosomal RNA (rRNA) genes. RRNA is the indispensable part of the cell that creates proteins. It is one of the primary targets of antibiotics, but rRNA mutation is now a well-known route to resistance. That resistance has many healthcare professionals concerned. In a recently presented study at EuroPerio9 in Amsterdam titled, “Antibiotic resistance trends in human periodontitis microbiota (2008–2015)”, results showed that antimicrobial resistance is on the rise among German patients with severe periodontitis.
Dr Kei Kitahara, a molecular microbiologist at Hokkaido University and co-author of the current paper, said: “Our results suggest that there are many unfound and uncharacterised antibiotic resistance point mutations in rRNA genes.”
In order for Kitahara and co-author Prof. Kentaro Miyazaki to arrive at this conclusion, they took rRNA from a wide range of bacterial species in the natural, or non-clinical, environment, where mutations are continually taking place. From there, the researchers were able to insert them into inactive Escherichia coli lacking in rRNA and found that more than 2,000 imported rRNA could compensate for this lack, thereby preventing the E. coli from dying. They then tested whether a common antibiotic, spectinomycin, effectively killed the bacteria or if the rRNA gave the E. coli resistance.
According to the study results, the screening found three previously unreported mutations in rRNA from the pathogens that resisted the antibiotic, along with other mutations that were already known. Although using inactive E. coli to test for mutations has been proposed before, this screening can analyse rRNA from other pathogens rather than just what is present in the E. coli.
The discovery by the researchers comes at a time when antibiotic research is becoming increasingly challenging. Earlier this year, the Star Tribune reported that Novartis, a Swiss multinational pharmaceutical company based in Basel, was the latest drug-manufacturing giant to announce it was shutting down its antibiotics and antiviral research programmes. According to the article, a Novartis representative said the move would allow the firm to “prioritise resources in other areas where we believe we are better positioned to develop innovative medicines”.
Looking to the future and possible next steps, Kitahara said: “We hope our method could be used to verify antibiotic resistance mutations, and contribute to the development of a database for the discovery and diagnosis of resistant bacteria.”
The study, titled “Functional metagenomic approach to identify overlooked antibiotic resistance mutations in bacterial rRNA”, was published in Scientific Reports on 3 April 2018.
Tags:
According to Dr Wendy Thompson, who is a dentist and clinical lecturer in primary dental care at the University of Manchester in the UK, the dental ...
LONDON, UK: Antimicrobial resistance (AMR) influences the success of medical treatment and allows for unhindered diffusion of bacteria. Although antibiotic ...
AMSTERDAM, Netherlands: Antimicrobial resistance is on the rise among German patients with severe periodontitis according to the findings of a ...
PHILADELPHIA, U.S.: Some young children experience severe dental caries that resists normal therapies. According to a recent study carried out by ...
LONDON, UK: According to a new study, dentists in England wrote 25% more prescriptions for antibiotics between April and July 2020 than they did during the ...
CINCINNATI, US: The prevalence of gingivitis continues to be a significant public health concern, and barriers such as limited access to healthcare and high...
BASEL, Switzerland: In a new study at the University of Basel, researchers have investigated how cariogenic bacteria manage to survive in dental plaque, ...
HELSINKI, Finland: Antibiotic overprescribing continues to be a major concern in dentistry. In most cases, readily prescribing antibiotics to patients ...
BETHLEHEM, Pa., US: Aggressive forms of periodontitis associated with Aggregatibacter actinomycetemcomitans are often difficult to treat with traditional ...
KAUNAS, Lithuania: The work of dental professionals was significantly affected by the COVID-19 outbreak. For this reason, researchers from Lithuania have ...
Live webinar
Thu. 18 July 2024
8:00 pm EST (New York)
Live webinar
Tue. 6 August 2024
6:00 pm EST (New York)
Live webinar
Tue. 13 August 2024
7:00 pm EST (New York)
Live webinar
Wed. 21 August 2024
9:00 am EST (New York)
Dr. Jim Lai DMD, MSc(Perio), EdD, FRCD(C)
Live webinar
Wed. 28 August 2024
8:00 pm EST (New York)
Live webinar
Mon. 2 September 2024
5:00 am EST (New York)
Live webinar
Tue. 3 September 2024
11:00 am EST (New York)
To post a reply please login or register